Product Information
TETRACYCLINE 500 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.5721 per EA under NDC 00591247501. Its NADAC has been published 533 times since Jun 8, 2016.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591247501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TETRACYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA061837FDA Approved
Before 1982
TE Code
AB
On Market Since
8/15/2011
Pharmacological Classes
Price Statistics
The NADAC for TETRACYCLINE 500 MG CAPSULE has been published 533 times since Jun 8, 2016, and over the history we have for it it has declined 94.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5721 per EA |
|---|---|
| All-time high | $11.1479 (Jun 15, 2016) |
| All-time low | $0.5721 (Aug 19, 2026) |
| 52-week high | $0.7825 |
| 52-week low | $0.5721 |
| Median price | $1.5590 |
| Average price | $2.7697 |
| Largest weekly change | +103.4% (Dec 22, 2021) |
| Weeks tracked | 533 |
| Tracking since | Jun 8, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TETRACYCLINE 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TETRACYCLINE 500 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.5721 per EA (NDC 00591247501), effective Aug 19, 2026.
How has the price of TETRACYCLINE 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TETRACYCLINE 500 MG CAPSULE has declined 94.9%. It has been tracked across 533 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for TETRACYCLINE 500 MG CAPSULE?
Since Jun 8, 2016, the NADAC for TETRACYCLINE 500 MG CAPSULE has ranged from a low of $0.5721 (Aug 19, 2026) to a high of $11.1479 (Jun 15, 2016), with a median of $1.5590 per EA.
Are there cheaper alternatives to TETRACYCLINE 500 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TETRACYCLINE 500 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TETRACYCLINE 500 MG CAPSULE?
TETRACYCLINE 500 MG CAPSULE (NDC 00591247501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.